Figure 2.
Epitope numbers in patients are related with severity
(A and B) The distribution of the numbers of the responsive epitopes in both the COVID-19 (n = 1,004) and control groups (n = 528). For the COVID-19 group, samples collected less than 15 days after symptom onset were excluded.
(C) The numbers of the responsive epitopes in the three groups with regard to severity and outcome.
(D) The S1 IgG signal intensity of the samples with different numbers of the responsive epitopes.
For (B)–(D), the data were presented by mean + SD. p values were calculated using the two-sided t test for others. For (C), the p value was adjusted for multiple comparisons by BH (Benjamini and Hochberg) method.